Cardlytics Stock Performance
| CDLX Stock | USD 12.31 0.72 6.21% |
Cardlytics holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.04, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardlytics will likely underperform. Use Cardlytics expected short fall, and the relationship between the maximum drawdown and rate of daily change , to analyze future returns on Cardlytics.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cardlytics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Cardlytics showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 6.26 | Five Day Return (1.83) | Year To Date Return 38.31 | Ten Year Return (7.93) | All Time Return (7.93) |
1 | Acquisition by Karim Temsamani of 84078 shares of Cardlytics subject to Rule 16b-3 | 03/01/2024 |
2 | Disposition of 34515 shares by Karim Temsamani of Cardlytics at 7.89 subject to Rule 16b-3 | 03/04/2024 |
3 | Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635 | 03/08/2024 |
4 | Cardlytics insider Clifford Sosin buys 8.96m in stock | 03/18/2024 |
5 | Cardlytics Prices 150.0 Million Convertible Senior Notes Offering | 03/27/2024 |
6 | Disposition of 50000 shares by Karim Temsamani of Cardlytics subject to Rule 16b-3 | 04/01/2024 |
7 | Why Cardlytics Stock Skyrocketed 75 percent Last Month | 04/02/2024 |
8 | Cardlytics exec sells over 170k in company stock | 04/03/2024 |
9 | Disposition of 32564 shares by Karim Temsamani of Cardlytics at 13.69 subject to Rule 16b-3 | 04/05/2024 |
10 | Is There An Opportunity With Cardlytics, Inc.s 31 percent Undervaluation | 04/08/2024 |
11 | Cardlytics shares get price target boost from Cardlytics | 04/09/2024 |
12 | Disposition of 682 shares by Lynton Nicholas Hollmeyer of Cardlytics subject to Rule 16b-3 | 04/22/2024 |
13 | Disposition of 23416 shares by Amit Gupta of Cardlytics at 11.91 subject to Rule 16b-3 | 04/24/2024 |
14 | Cardlytics Inc COO Amit Gupta Sells 23,416 Shares | 04/25/2024 |
| Begin Period Cash Flow | 122 M |
Cardlytics |
Cardlytics Relative Risk vs. Return Landscape
If you would invest 804.00 in Cardlytics on January 30, 2024 and sell it today you would earn a total of 427.00 from holding Cardlytics or generate 53.11% return on investment over 90 days. Cardlytics is currently generating 1.2785% in daily expected returns and assumes 12.2152% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Cardlytics, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cardlytics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardlytics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cardlytics, and traders can use it to determine the average amount a Cardlytics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1047
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CDLX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.22 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.28 actual daily | 25 75% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Cardlytics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardlytics by adding it to a well-diversified portfolio.
Cardlytics Fundamentals Growth
Cardlytics Stock prices reflect investors' perceptions of the future prospects and financial health of Cardlytics, and Cardlytics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cardlytics Stock performance.
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.0629 | ||||
| Profit Margin | (0.44) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 717.26 M | ||||
| Shares Outstanding | 48.17 M | ||||
| Price To Earning | (3.47) X | ||||
| Price To Book | 4.44 X | ||||
| Price To Sales | 1.94 X | ||||
| Revenue | 309.2 M | ||||
| Gross Profit | 115.42 M | ||||
| EBITDA | (34.15 M) | ||||
| Net Income | (134.7 M) | ||||
| Cash And Equivalents | 157.04 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 266.11 M | ||||
| Debt To Equity | 0.42 % | ||||
| Current Ratio | 0.90 X | ||||
| Book Value Per Share | 3.39 X | ||||
| Cash Flow From Operations | (185 K) | ||||
| Earnings Per Share | (3.69) X | ||||
| Market Capitalization | 593.02 M | ||||
| Total Asset | 574.14 M | ||||
| Retained Earnings | (1.11 B) | ||||
| Working Capital | 52.78 M | ||||
| Current Asset | 81.93 M | ||||
| Current Liabilities | 52.77 M | ||||
About Cardlytics Performance
To evaluate Cardlytics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Cardlytics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Cardlytics Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Cardlytics market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Cardlytics's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.18 | 0.17 | |
| Return On Tangible Assets | (0.57) | (0.60) | |
| Return On Capital Employed | (0.16) | (0.17) | |
| Return On Assets | (0.23) | (0.25) | |
| Return On Equity | (1.00) | (1.05) |
Things to note about Cardlytics performance evaluation
Checking the ongoing alerts about Cardlytics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cardlytics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cardlytics is way too risky over 90 days horizon | |
| Cardlytics appears to be risky and price may revert if volatility continues | |
| The company currently holds 266.11 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cardlytics until it has trouble settling it off, either with new capital or with free cash flow. So, Cardlytics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cardlytics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cardlytics to invest in growth at high rates of return. When we think about Cardlytics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 309.2 M. Net Loss for the year was (134.7 M) with profit before overhead, payroll, taxes, and interest of 115.42 M. | |
| Cardlytics currently holds about 157.04 M in cash with (185 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77. | |
| Roughly 64.0% of Cardlytics shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Cardlytics Inc COO Amit Gupta Sells 23,416 Shares |
- Analyzing Cardlytics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cardlytics' stock is overvalued or undervalued compared to its peers.
- Examining Cardlytics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cardlytics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cardlytics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cardlytics' stock. These opinions can provide insight into Cardlytics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardlytics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Cardlytics Stock analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Cardlytics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. If investors know Cardlytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardlytics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.57) | Earnings Share (3.69) | Revenue Per Share 8.474 | Quarterly Revenue Growth 0.081 | Return On Assets (0.06) |
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardlytics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardlytics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardlytics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.